newsGoogle News — Machine LearningTrust 62 · AggregatorPublished 25d agoLive · 24d ago
Machine learning for drug metabolism prediction: CYPs, Phase II enzymes, and metabolite ID - Drug Discovery News
Machine learning for drug metabolism prediction: CYPs, Phase II enzymes, and metabolite ID Drug Discovery News
Why these links exist
Every edge carries a method, confidence, and the source snippet that justified it — so bad links are debuggable.
- PossiblePossibly related (embedding) · 60%rdk/p2rank →
- PossiblePossibly related (embedding) · 54%Explainable AI for Cancer Drug Response Prediction: Beyond Univariate Feature Attributions →
- PossiblePossibly related (embedding) · 54%$\mathtt{Q^2SAR}$: overcoming classical bottlenecks in drug discovery via quantum multiple kernel learning →
- PossiblePossibly related (embedding) · 54%Beyond Drug Discovery: The Nanotechnology Molecular Optimization (NMO) Benchmark →
- PossiblePossibly related (embedding) · 52%URSA: Chemistry-Aware Benchmark for Utilitarian Retrosynthesis Assessment →
Covers
repordk/p2rankpaperExplainable AI for Cancer Drug Response Prediction: Beyond Univariate Feature Attributionspaper$\mathtt{Q^2SAR}$: overcoming classical bottlenecks in drug discovery via quantum multiple kernel learningpaperBeyond Drug Discovery: The Nanotechnology Molecular Optimization (NMO) BenchmarkpaperURSA: Chemistry-Aware Benchmark for Utilitarian Retrosynthesis Assessment
Related across the graph
paperBeyond Drug Discovery: The Nanotechnology Molecular Optimization (NMO) Benchmarkrepordk/p2rankpaper$\mathtt{Q^2SAR}$: overcoming classical bottlenecks in drug discovery via quantum multiple kernel learningpaperURSA: Chemistry-Aware Benchmark for Utilitarian Retrosynthesis AssessmentpaperExplainable AI for Cancer Drug Response Prediction: Beyond Univariate Feature Attributions